Authors: Cooke, KR Gerbitz, A Crawford, JM Teshima, T Hill, GR Tesolin, A Rossignol, DP Ferrara, JLM

Citation: Kr. Cooke et al., LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation, J CLIN INV, 107(12), 2001, pp. 1581-1589

Authors: Rose, JR Mullarkey, MA Christ, WJ Hawkins, LD Lynn, M Kishi, Y Wasan, KM Peteherych, K Rossignol, DP

Citation: Jr. Rose et al., Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteins, ANTIM AG CH, 44(3), 2000, pp. 504-510

Authors: Wasan, KM Strobel, FW Parrott, SC Lynn, M Christ, WJ Hawkins, LD Rossignol, DP

Citation: Km. Wasan et al., Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasmafrom human subjects with various lipid levels, ANTIM AG CH, 43(10), 1999, pp. 2562-2564

Authors: Kawata, T Bristol, JR Rossignol, DP Rose, JR Kobayashi, S Yokohama, H Ishibashi, A Christ, WJ Katayama, K Yamatsu, I Kishi, Y

Citation: T. Kawata et al., E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharide, BR J PHARM, 127(4), 1999, pp. 853-862

Authors: Rossignol, DP Hawkins, LD Christ, WJ Kobayashi, S Kawata, T Lynn, M Yamatsu, I Kishi, Y

Citation: Dp. Rossignol et al., Synthetic endotoxin antagonists, ENDOTOXIN IN HEALTH AND DISEASE, 1999, pp. 699-717